Sensors inspired by nature
Sencilia is trusted by
Discover Sencilia: Transforming MedTech!
Sencilia, an early-stage MedTech startup, is a spin-off from the Bioinspired MEMS and Biomedical Devices (BMBD) group at the University of Groningen. Dr. Amar M. Kamat (former postdoc in BMBD and currently the CEO of Sencilia) and Prof. Ajay G.P. Kottapalli (Associate Professor and Chair of the BMBD group) founded Sencilia in Sep 2021 in order to utilize and valorize the extensive knowhow in sensor technology and nanofabrication generated within the BMBD group over many years.
Sencilia aims to enhance the safety of IV infusion therapy, and harbors the vision of becoming the standard of care in IV drug administration by 2030.
Currently at a design/development stage (TRL = 4), we're partnering with world-renowned hospitals such as Erasmus MC and UMCG to co-develop our product, and are aiming for a market launch in 2026. Join us on this exciting journey as we revolutionize IV infusion monitoring technology!
Introducing Rely-V
Core Team
Amar oversees the technology and business development activities at Sencilia
Dr. Amar M. Kamat, PhD
Founder and CEO
Natanael leads the R&D efforts in hardware/software development
Ir. Natanael Gomes, MSc
Co-CTO
Ajay acts as the chief advisor on micro and nano fabrication
Prof. Dr. Ajay G.P. Kottapalli, PhD
Scientific Founder and Technology Advisor
Associate Professor and Chair of BMBD group, University of Groningen
Leon acts as the chief advisor on business development and strategic partnerships
Dr. Leon Ramselaar, PhD MBA
Business Advisor and Strategic Partnerships Lead
Thom specializes in design, prototyping, testing and fabrication
Ir. Thom van der Honing, BSc
Biomedical Design Engineer
Advisors
Dr. Anna-Linda Peters (MD PhD)
Clinical Advisor
Anesthesiologist and Intensive Care Fellow, UMC Amsterdam
Roland van Rens, MA
Clinical (Nursing) Advisor
Senior NICU nurse and PhD candidate, Radboud University
Any questions? Let's talk!
Sencilia Timeline
2020
June
2021
June
September
2022
February
July
September
December
Sencilia is selected to join imec.istart.nl, a world-leading accelerator program for tech startups
2023
April
June
Sencilia successfully completes the Venture Challenge program organized by life sciences@work, NWO and Health Holland
The SmartInfuus project (led by Sencilia in collaboration with the UMCG and University of Groningen) is awarded the SNN Valorisatie 2022 subsidy (€321k) by the European Regional Development Funds (ERDF) to perform preclinical validation of its technology
July
Sencilia is awarded the NWO Take-off 2 subsidy (€250k) as early-stage financing (vroegfasefinanciering) to continue its technology and business development
November
December
Sencilia is selected as one of the winners of the Academic Startup Competition 2024 organized by TeachLeapNL